Costa Rica Continues To Strengthen Its Position As A Leading Hub For Life Sciences Companies


(MENAFN- PR Newswire)

"Our participation in MD&M West 2025 is an opportunity to showcase the growth and dynamism of Costa Rica's life sciences sector to the world. We will engage in a robust agenda of meetings with potential investors while staying at the forefront of the latest industry trends," said Marianela Urgellés Batalla, Managing Director of CINDE.

This participation comes amid recent announcements from global life sciences companies expanding their operations in Costa Rica. Among them is Harland Medical Systems, which recently launched operations in the country. Its new facility at The Green Park Free Zone in Alajuela will focus on manufacturing hydrophilic coatings, further expanding the supplier ecosystem and strengthening the industry's value chain.

Meanwhile, Edwards Lifesciences, renowned for its cutting-edge cardiovascular disease treatments, has diversified and expanded its Costa Rica operations with the opening of a new Corporate Services Center (CSC) at La Lima Business Park in Cartago.

Since 2017, Costa Rica's medical device exports have grown at an average annual rate of 18%, surpassing $8 billion in 2024. This rapid expansion has positioned the country as Latin America's second-largest exporter of medical devices and the fifth-largest supplier of these products to the United States.

For more information on Costa Rica's participation in MD&M West 2025 and investment opportunities in the life sciences sector, visit .

About CINDE

CINDE is Costa Rica's expert and strategic partner in investment promotion, business development, and talent initiatives. With over 43 years of experience working alongside multinational companies, CINDE has played a key role in shaping Costa Rica's investment ecosystem. The organization has led numerous talent development initiatives, reinforcing the country's business climate and supporting the establishment of over 450 multinational companies.

SOURCE CINDE

MENAFN03022025003732001241ID1109162806


PR Newswire

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.